Paper40569488
A Guide to the Evolving Clinical Landscape of Low-Level Viremia Among Persons with HIV in the Modern Treatment Era.
Aldredge A and 3 others. Curr HIV/AIDS Rep, 2025. Cited by 3 papers, by iCite.
Cite this record
ConductScience Library. A Guide to the Evolving Clinical Landscape of Low-Level Viremia Among Persons with HIV in the Modern Treatment Era. Papers, record 40569488. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40569488
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- A Guide to the Evolving Clinical Landscape of Low-Level Viremia Among Persons with HIV in the Modern Treatment Era.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| HIV Infections | Major topic |
| Viremia | Major topic |
| Anti-HIV Agents | Major topic |
| Humans | |
| Female | |
| Risk Factors | |
| Viral Load | |
| Male |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| K23 AG084415 | NIA NIH HHS | United States | K23AG084415 | PubMed and NIH | NIH RePORTER |
| T32 AI157855 | NIAID NIH HHS | United States | T32AI157855 | PubMed and NIH | NIH RePORTER |
| P30AI050409 | Center for AIDS Research, Emory University | P30AI050409 | PubMed | NIH RePORTER | |
| K23AG084415 | National Institute on Aging (NIA) of the NIH | K23AG084415 | PubMed and NIH | NIH RePORTER |
References134
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 37957382 | Viral and host mediators of non-suppressible HIV-1 viremia. | Nat Med | 2023 | https://conductscience.org/library/papers/37957382 | PubMed |
| 2 | 18192682 | Episodes of low-level viral rebound in HIV-infected patients on antiretroviral therapy: frequency, predictors and outcome. | J Antimicrob Chemother | 2008 | https://conductscience.org/library/papers/18192682 | PubMed |
| 3 | 38390465 | Clinical Relevance of Human Immunodeficiency Virus Low-level Viremia in the Dolutegravir era: Data From the Viral Load Cohort North-East Lesotho (VICONEL). | Open Forum Infect Dis | 2024 | https://conductscience.org/library/papers/38390465 | PubMed |
| 4 | 24361679 | Incomplete adherence to antiretroviral therapy is associated with higher levels of residual HIV-1 viremia. | AIDS | 2014 | https://conductscience.org/library/papers/24361679 | PubMed |
| 5 | 36400087 | Low-level viraemia among people living with HIV in Nigeria: a retrospective longitudinal cohort study. | Lancet Glob Health | 2022 | https://conductscience.org/library/papers/36400087 | PubMed |
| 6 | 31306175 | Low-level viremia and virologic failure in persons with HIV infection treated with antiretroviral therapy. | AIDS | 2019 | https://conductscience.org/library/papers/31306175 | PubMed |
| 7 | 19055701 | Residual viraemia in HIV-1-infected patients with plasma viral load <or=20 copies/ml is associated with increased blood levels of soluble immune activation markers. | Scand J Immunol | 2008 | https://conductscience.org/library/papers/19055701 | PubMed |
| 8 | 25664219 | HIV Drug Resistance Profiles and Clinical Outcomes in Patients with Viremia Maintained at Very Low Levels. | World J AIDS | 2013 | https://conductscience.org/library/papers/25664219 | PubMed |
| 9 | 34966148 | Lower Incidence of HIV-1 Blips Observed During Integrase Inhibitor-Based Combination Antiretroviral Therapy. | J Acquir Immune Defic Syndr | 2022 | https://conductscience.org/library/papers/34966148 | PubMed |
| 10 | 26165150 | HIV-1 Very Low Level Viremia Is Associated with Virological Failure in Highly Active Antiretroviral Treatment-Treated Patients. | AIDS Res Hum Retroviruses | 2015 | https://conductscience.org/library/papers/26165150 | PubMed |
| 11 | 28299369 | Socioeconomic status and treatment outcomes for individuals with HIV on antiretroviral treatment in the UK: cross-sectional and longitudinal analyses. | Lancet Public Health | 2016 | https://conductscience.org/library/papers/28299369 | PubMed |
| 12 | 39110550 | Consequences of low-level viremia among women with HIV in the United States. | AIDS | 2024 | https://conductscience.org/library/papers/39110550 | PubMed |
| 13 | 37831614 | Predictors of Post-switch Viremia in People With HIV on Injectable Cabotegravir/Rilpivirine. | J Acquir Immune Defic Syndr | 2024 | https://conductscience.org/library/papers/37831614 | PubMed |
| 14 | 26566025 | Factors Associated with Low-Level Viraemia and Virological Failure: Results from the Austrian HIV Cohort Study. | PLoS One | 2015 | https://conductscience.org/library/papers/26566025 | PubMed |
| 15 | 32794406 | Low-level HIV viremia is associated with low antiretroviral prescription refill rates and social deprivation. | AIDS Care | 2021 | https://conductscience.org/library/papers/32794406 | PubMed |
| 16 | 35578387 | Association of low-level viremia with mortality among people living with HIV on antiretroviral therapy in Dehong, Southwest China: A retrospective cohort study. | HIV Med | 2023 | https://conductscience.org/library/papers/35578387 | PubMed |
| 17 | 33331635 | Prevalence of drug resistance mutations in HIV-infected individuals with low-level viraemia under combination antiretroviral therapy: an observational study in a tertiary hospital in Northern Taiwan, 2017-19. | J Antimicrob Chemother | 2021 | https://conductscience.org/library/papers/33331635 | PubMed |
| 18 | 24451160 | HIV drug resistance detected during low-level viraemia is associated with subsequent virologic failure. | AIDS | 2014 | https://conductscience.org/library/papers/24451160 | PubMed |
| 19 | 24733471 | Significance and clinical management of persistent low-level viremia and very-low-level viremia in HIV-1-infected patients. | Antimicrob Agents Chemother | 2014 | https://conductscience.org/library/papers/24733471 | PubMed |
| 20 | 37721192 | Low-level HIV viraemia during antiretroviral therapy: Longitudinal patterns and predictors of viral suppression. | HIV Med | 2024 | https://conductscience.org/library/papers/37721192 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42713136 | Residual HIV activity and host immunometabolic remodeling during antiretroviral therapy: implications for cardiovascular-kidney-metabolic risk. | Front Immunol | 2026 | https://conductscience.org/library/papers/42713136 | PubMed |
| 42640012 | Long-Acting Injectable Antiretroviral Therapies for HIV Treatment and Prevention: Clinical Pharmacology, Recent Advances and Future Opportunities. | J Clin Pharmacol | 2026 | https://conductscience.org/library/papers/42640012 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40569488
GET https://conductscience.org/api/papers/v1/40569488/references?page=2